Nasdaq · CIK 0001551306
PGNY Progyny, Inc.
Insider trading from SEC Form 4. Last filing 15 d ago. Close $27.93 on Oct 9, 2026, +71% from the 52-week low and -14% from the high.
In brief
Progyny, Inc. (PGNY) has 91 SEC Form 4 filings on file from 13 insiders, the latest filed on Sep 28, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 4 open-market sells worth $806k, net -$806k.
27 open-market trades have been scored at PGNY. The newest: Allison Swartz (EVP, GC) sold $102k of stock on Sep 23, 2026, filed Sep 28, 2026, scored 13 (weak), under a 10b5-1 plan. The largest of the 27 shown: Peter Anevski (CHIEF EXECUTIVE OFFICER) bought $3.0M on Dec 23, 2024, scored 68 (notable). 2 insiders sold within 14 days of each other around Sep 23, 2026.
1 member of Congress has disclosed 1 trade in PGNY under the STOCK Act. 25 Form 144 notices of planned sales are on file, the latest filed Sep 23, 2026.
Last 90 days
Net insider value
-$806k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
4
$806k by 3 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
PGNYOct 9, 2026 · close 27.93
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Progyny, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Allison Swartz EVP, GC sell | $102k 3,903 shares | -5% | +58% from low-20% from high | |
| 42Moderate | Kevin K Gordon director sell | $312k 11,500 shares | -63% | +66% from low-16% from high | |
| 42Moderate | Kevin K Gordon director sell | $321k 11,500 shares | -63% | +66% from low-16% from high | |
| 8Weak | Melissa B Cummings Chief Operating Officer sell | $71k 2,244 shares | -3% | +99% from low0% from high | |
| 25Weak | Mark S. Livingston CHIEF FINANCIAL OFFICER sell | $64k 2,517 shares | -3% | +56% from low-10% from high | |
| 16Weak | Allison Swartz EVP, GC sell | $45k 1,798 shares | -2% | +53% from low-12% from high | |
| 21Weak | Geoffrey Clapp Chief Product Officer sell | $39k 1,530 shares | -3% | +54% from low-12% from high | |
| 17Weak | Mark S. Livingston CHIEF FINANCIAL OFFICER sell | $7,310 279 shares | -0% | +54% from low-12% from high | |
| 37Weak | Cheryl Scott director sell | $196k 7,439 shares | -27% | +61% from low-8% from high | |
| 17Weak | Allison Swartz EVP, GC sell | $61k 2,398 shares | -3% | +58% from low-10% from high | |
| 51Moderate | Kevin K Gordon director sell | $137k 5,500 shares | -37% | +56% from low-10% from high | |
| 33Weak | Melissa B Cummings Chief Operating Officer sell | $239k 9,578 shares | -12% | +51% from low-13% from high | |
| 29Weak | Mark S. Livingston CHIEF FINANCIAL OFFICER sell | $211k 8,275 shares | -9% | +57% from low-10% from high | |
| 0Weak | Allison Swartz EVP, GC sell | $11k 599 shares | -1% | +2% from low-37% from high | |
| 5Weak | Allison Swartz EVP, GC sell | $119k 6,856 shares | -7% | 0% from low-38% from high | |
| 10Weak | Mark S. Livingston CHIEF FINANCIAL OFFICER sell | $12k 459 shares | -1% | +83% from low-3% from high | |
| 3Weak | Allison Swartz EVP, GC sell | $13k 530 shares | -1% | +70% from low-10% from high | |
| 10Weak | Mark S. Livingston CHIEF FINANCIAL OFFICER sell | $5,432 213 shares | -0% | +76% from low-7% from high | |
| 11Weak | Allison Swartz EVP, GC sell | $64k 2,398 shares | -3% | +86% from low-2% from high | |
| 39Weak | Mark S. Livingston CHIEF FINANCIAL OFFICER sell | $543k 21,303 shares | -31% | +96% from low0% from high | |
| 53Moderate | Peter Anevski CHIEF EXECUTIVE OFFICER buy | $1.9M 79,500 shares | +13% | +79% from low0% from high | |
| 0Weak | Allison Swartz EVP, GC sell | $14k 599 shares | -1% | +72% from low-5% from high | |
| 2Weak | Allison Swartz EVP, GC sell | $55k 2,398 shares | -3% | +70% from low-6% from high | |
| 27Weak | Kevin K Gordon director sell | $55k 2,500 shares | -17% | +59% from low-12% from high | |
| 27Weak | Cheryl Scott director sell | $59k 2,675 shares | -16% | +59% from low-13% from high | |
| 68Notable | Peter Anevski CHIEF EXECUTIVE OFFICER buy | $3.0M 209,500 shares | +90% | - | |
| 63Notable | David J Schlanger Executive Chairman buy | $2.2M 150,000 shares | +192% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 23, 2026 | Swartz Allison Officer | 3,903 0.01% of outstanding | $102k | Sep 23, 2026 | none |
| Sep 10, 2026 | GORDON KEVIN K Director | 11,500 0.01% of outstanding | $312k | Sep 10, 2026 | none |
| Jul 14, 2026 | Cummings Melissa B Officer | 2,244 0.00% of outstanding | $71k | Jul 14, 2026 | $239k |
| Jun 4, 2026 | Livingston Mark S. Officer | 2,517 0.00% of outstanding | $64k | Jun 4, 2026 | $218k |
| Jun 4, 2026 | Swartz Allison Officer | 599 0.00% of outstanding | $15k | Jun 4, 2026 | $102k |
| Jun 3, 2026 | Swartz Allison Officer | 1,199 0.00% of outstanding | $30k | Jun 3, 2026 | $153k |
| Jun 2, 2026 | Clapp Geoffrey Officer | 1,530 0.00% of outstanding | $39k | Jun 2, 2026 | none |
| Jun 2, 2026 | Livingston Mark S. Officer | 279 0.00% of outstanding | $7,310 | Jun 2, 2026 | $211k |
| Jun 1, 2026 | Scott Cheryl Director | 7,439 0.01% of outstanding | $196k | Jun 1, 2026 | $66k |
| May 28, 2026 | Swartz Allison Officer | 2,398 0.00% of outstanding | $61k | May 28, 2026 | $130k |
| May 27, 2026 | GORDON KEVIN K Director | 5,500 0.01% of outstanding | $137k | May 27, 2026 | none |
| May 22, 2026 | Scott Cheryl Director | 2,676 0.00% of outstanding | $66k | May 22, 2026 | none |
| May 20, 2026 | Livingston Mark S. Officer | 8,275 0.01% of outstanding | $211k | May 20, 2026 | none |
| May 19, 2026 | Cummings Melissa B Officer | 9,578 0.01% of outstanding | $239k | May 19, 2026 | none |
| Mar 4, 2026 | Swartz Allison Officer | 599 0.00% of outstanding | $11k | Mar 4, 2026 | $132k |
| Mar 3, 2026 | Swartz Allison Officer | 4,657 0.01% of outstanding | $81k | Mar 3, 2026 | $51k |
| Mar 2, 2026 | Swartz Allison Officer | 2,199 0.00% of outstanding | $38k | Mar 2, 2026 | $13k |
| Dec 11, 2025 | Livingston Mark S. Officer | 459 0.00% of outstanding | $12k | Dec 11, 2025 | $549k |
| Dec 4, 2025 | Swartz Allison Officer | 530 0.00% of outstanding | $13k | Dec 4, 2025 | $79k |
| Dec 2, 2025 | Livingston Mark S. Officer | 213 0.00% of outstanding | $5,432 | Dec 2, 2025 | $543k |
| Nov 28, 2025 | Swartz Allison Officer | 2,398 0.00% of outstanding | $64k | Nov 28, 2025 | $69k |
| Nov 17, 2025 | Livingston Mark S. Officer | 21,303 0.02% of outstanding | $543k | Nov 17, 2025 | none |
| Sep 4, 2025 | Swartz Allison Officer | 599 0.00% of outstanding | $14k | Sep 4, 2025 | $55k |
| Aug 28, 2025 | Swartz Allison Officer | 2,398 0.00% of outstanding | $55k | Aug 28, 2025 | none |
| Aug 11, 2025 | GORDON KEVIN K Director | 2,500 0.00% of outstanding | $55k | Aug 11, 2025 | none |
Congressional trades
1 trade in PGNY disclosed by members of Congress under the STOCK Act. All congressional trades.
- Josh GottheimerHouse · D-NJ · last Jan 14, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Josh Gottheimer House · D-NJ | Sale | PGNY Progyny, Inc. - Common Stock | $1,001 to $15k | Dec 6, 2024 / Jan 14, 2025 39 days after the trade | Clerk |
Transactions
The newest 50 of 164 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Allison Swartz EVP, GC | SOpen-market sale Common Stock10b5-1 | -3,903 | $26.10 | $102k | 75,816 | 15 d ago |
| Sep 17, 2026 | Geoffrey Clapp Chief Product Officer | FTax withholding Common Stock | -819 | $27.38 | $22k | 59,009 | 22 d ago |
| Sep 10, 2026 | Kevin K Gordon director | MOption exercise Common Stock | +22,000 | $13.00 | $286k | 28,792 | 25 d ago |
| Sep 10, 2026 | Kevin K Gordon director | FTax withholding Common Stock | -10,500 | $27.24 | $286k | 18,292 | 25 d ago |
| Sep 10, 2026 | Kevin K Gordon director | SOpen-market sale Common Stock | -11,500 | $27.12 | $312k | 6,792 | 25 d ago |
| Sep 10, 2026 | Kevin K Gordon director | MOption exercise Stock Option (Right to Buy)derivative | -22,000 | $0.00 | $0 | 22,000 | 25 d ago |
| Sep 10, 2026 | Kevin K Gordon director | MOption exercise Common Stock | +22,000 | $13.00 | $286k | 28,792 | 29 d ago |
| Sep 10, 2026 | Kevin K Gordon director | FTax withholding Common Stock | -10,500 | $27.24 | $286k | 18,292 | 29 d ago |
| Sep 10, 2026 | Kevin K Gordon director | SOpen-market sale Common Stock | -11,500 | $27.94 | $321k | 6,792 | 29 d ago |
| Sep 10, 2026 | Kevin K Gordon director | MOption exercise Stock Option (Right to Buy)derivative | -22,000 | $0.00 | $0 | 22,000 | 29 d ago |
| Sep 3, 2026 | Peter Anevski CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -5,361 | $26.29 | $141k | 806,111 | 35 d ago |
| Sep 4, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -479 | $26.61 | $13k | 72,453 | 35 d ago |
| Sep 3, 2026 | Allison Swartz EVP, GC | FTax withholding Common Stock | -828 | $26.29 | $22k | 80,198 | 35 d ago |
| Sep 4, 2026 | Allison Swartz EVP, GC | FTax withholding Common Stock | -479 | $26.61 | $13k | 79,719 | 35 d ago |
| Sep 2, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -224 | $25.66 | $5,748 | 74,464 | 39 d ago |
| Sep 3, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,532 | $26.29 | $40k | 72,932 | 39 d ago |
| Aug 28, 2026 | Allison Swartz EVP, GC | FTax withholding Common Stock | -1,352 | $25.86 | $35k | 81,026 | 42 d ago |
| Jul 14, 2026 | Melissa B Cummings Chief Operating Officer | FTax withholding Common Stock10b5-1 | -1,193 | $31.98 | $38k | 72,178 | Jul 16, 2026 |
| Jul 14, 2026 | Melissa B Cummings Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -2,244 | $31.60 | $71k | 69,934 | Jul 16, 2026 |
| Jun 17, 2026 | Geoffrey Clapp Chief Product Officer | FTax withholding Common Stock | -819 | $26.60 | $22k | 59,828 | Jun 23, 2026 |
| Jun 3, 2026 | Peter Anevski CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -5,361 | $25.12 | $135k | 811,472 | Jun 5, 2026 |
| Jun 3, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | FTax withholding Common Stock10b5-1 | -1,082 | $25.12 | $27k | 77,544 | Jun 5, 2026 |
| Jun 3, 2026 | Allison Swartz EVP, GC | FTax withholding Common Stock10b5-1 | -676 | $25.12 | $17k | 84,515 | Jun 5, 2026 |
| Jun 4, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | FTax withholding Common Stock10b5-1 | -339 | $24.99 | $8,472 | 77,205 | Jun 5, 2026 |
| Jun 3, 2026 | Allison Swartz EVP, GC | SOpen-market sale Common Stock10b5-1 | -1,199 | $25.02 | $30k | 83,316 | Jun 5, 2026 |
| Jun 4, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -1,918 | $25.50 | $49k | 75,287 | Jun 5, 2026 |
| Jun 4, 2026 | Allison Swartz EVP, GC | FTax withholding Common Stock10b5-1 | -339 | $24.99 | $8,472 | 82,977 | Jun 5, 2026 |
| Jun 4, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -599 | $25.50 | $15k | 74,688 | Jun 5, 2026 |
| Jun 4, 2026 | Allison Swartz EVP, GC | SOpen-market sale Common Stock10b5-1 | -599 | $25.08 | $15k | 82,378 | Jun 5, 2026 |
| Jun 2, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | FTax withholding Common Stock10b5-1 | -158 | $26.20 | $4,140 | 78,905 | Jun 3, 2026 |
| Jun 1, 2026 | Cheryl Scott director | MOption exercise Common Stock | +14,667 | $13.00 | $191k | 34,439 | Jun 3, 2026 |
| Jun 2, 2026 | Geoffrey Clapp Chief Product Officer | SOpen-market sale Common Stock | -1,530 | $25.58 | $39k | 59,117 | Jun 3, 2026 |
| Jun 2, 2026 | Mark S. Livingston CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -279 | $26.20 | $7,310 | 78,626 | Jun 3, 2026 |
| Jun 1, 2026 | Cheryl Scott director | FTax withholding Common Stock | -7,228 | $26.38 | $191k | 27,211 | Jun 3, 2026 |
| Jun 2, 2026 | Geoffrey Clapp Chief Product Officer | MOption exercise Common Stock | +12,909 | $20.91 | $270k | 72,026 | Jun 3, 2026 |
| Jun 2, 2026 | Geoffrey Clapp Chief Product Officer | FTax withholding Common Stock | -11,379 | $25.54 | $291k | 60,647 | Jun 3, 2026 |
| Jun 1, 2026 | Cheryl Scott director | SOpen-market sale Common Stock | -7,439 | $26.39 | $196k | 19,772 | Jun 3, 2026 |
| Jun 2, 2026 | Geoffrey Clapp Chief Product Officer | MOption exercise Stock Option (Right to Buy)derivative | -12,909 | $0.00 | $0 | 26,211 | Jun 3, 2026 |
| Jun 1, 2026 | Cheryl Scott director | MOption exercise Stock Option (Right to Buy)derivative | -14,667 | $0.00 | $0 | 29,333 | Jun 3, 2026 |
| May 28, 2026 | Allison Swartz EVP, GC | FTax withholding Common Stock10b5-1 | -1,352 | $25.48 | $34k | 87,589 | Jun 1, 2026 |
| May 28, 2026 | Allison Swartz EVP, GC | SOpen-market sale Common Stock10b5-1 | -2,398 | $25.46 | $61k | 85,191 | Jun 1, 2026 |
| May 27, 2026 | Kevin K Gordon director | SOpen-market sale Common Stock | -5,500 | $24.99 | $137k | 9,318 | May 29, 2026 |
| May 27, 2026 | Kevin K Gordon director | JOther Common Stock | -2,526 | $0.00 | $0 | 6,792 | May 29, 2026 |
| May 27, 2026 | Kevin K Gordon director | JOther Common Stockindirect: See footnote | +2,526 | $0.00 | $0 | 15,027 | May 29, 2026 |
| May 21, 2026 | Elizabeth D Bierbower director | AGrant or award Common Stock | +5,660 | $0.00 | $0 | 5,660 | May 26, 2026 |
| May 21, 2026 | Jeffrey G Park director | AGrant or award Common Stock | +7,924 | $0.00 | $0 | 39,981 | May 26, 2026 |
| May 21, 2026 | Debra L Morris director | AGrant or award Common Stock | +5,660 | $0.00 | $0 | 5,660 | May 26, 2026 |
| May 21, 2026 | Roger C Holstein director | AGrant or award Common Stock | +6,792 | $0.00 | $0 | 28,729 | May 26, 2026 |
| May 21, 2026 | Lloyd H Dean director | AGrant or award Common Stock | +6,792 | $0.00 | $0 | 26,519 | May 26, 2026 |
| May 21, 2026 | Kevin K Gordon director | AGrant or award Common Stock | +6,792 | $0.00 | $0 | 14,818 | May 26, 2026 |
50 of 164 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Peter AnevskiCHIEF EXECUTIVE OFFICER
- Elizabeth D Bierbowerdirector
- Geoffrey ClappChief Product Officer
- Melissa B CummingsChief Operating Officer
- Lloyd H Deandirector
- Kevin K Gordondirector
- Roger C Holsteindirector
- Mark S. LivingstonCHIEF FINANCIAL OFFICER
- Debra L Morrisdirector
- Jeffrey G Parkdirector
- David J SchlangerExecutive Chairman
- Cheryl Scottdirector
- Allison SwartzEVP, GC
Questions about PGNY
Answered from the filings on this page, as of the latest one.
Are insiders buying PGNY?
As of Sep 28, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 4 open-market sells worth $806k by 3 insiders at Progyny, Inc. in the last 90 days, net -$806k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade PGNY on the open market?
Allison Swartz (EVP, GC) sold $102k of PGNY on Sep 23, 2026 and filed the Form 4 on Sep 28, 2026. InsiderTell scored 13 (weak), under a 10b5-1 plan, with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Progyny, Inc.?
13 people have filed a Form 4 at Progyny, Inc., among them Peter Anevski (CHIEF EXECUTIVE OFFICER), Elizabeth D Bierbower (director), Geoffrey Clapp (Chief Product Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.